SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ZURA

Zura Bio Limited (NASDAQ:ZURA)

US · Delayed Price · Currency is USD
Also listed: 94E.FHealthcare · Biotechnology
4.09+0.37 (+9.95%)
 
Market cap
$394M
Insider Score
Health Score
Analyst consensus
Listed since
Mar 21, 2023
Market Cap393.97M+11.4%
Revenue (ttm)0
Net Income-93.53M-54.5%
EPS-1.12-41.8%
Shares Out96.33M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,001,495
Open3.80
Previous Close3.72
Day's Range3.76 - 4.25
52-Week Range3.25 - 7.44
Betan/a
AnalystsBuy
Price Target20.00(+389.00%)
Earnings DateMar 18, 2027
Insider Score
––Not scored
ZURA Insider Score

No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.

About ZURA

Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.

Address
1489 W. Warm Springs Road, Henderson, NV, 89014, US
Market Cap
394 million
Employees
40
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$12.50M

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
2 Buy0 Hold0 Sell

2 firms rating ZURA in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Fair
From ZURA’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

Ask Barron about ZURA

1 Day
+9.95%
5 Days
+1.24%
1 Month
-1.92%
6 Months
-9.91%
1 Year
+11.44%

$ZURA stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in ZURA holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ZURA's directors and management

Net Shares Purchased by Insiders−2M−1M02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ZURA Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New ZURA patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ZURA from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in ZURA

ETFEst. Holding Size
IWMiShares Russell 2000 ETF$5.73M
VXFVanguard Extended Market ETF$2.90M
IWOiShares Russell 2000 Growth ETF$2.09M
VTWOVanguard Russell 2000 ETF$1.43M
IWCiShares Micro-Cap ETF$668.93K
VFMOVanguard U.S. Momentum Factor ETF$510.76K

Estimated from each fund’s disclosed top holdings × AUM

ZURA Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for ZURA yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from ZURA’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
100% of score
99
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
1
Sells
0
Buy Value
$12.50M
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.